Inaktiver Wert

Immunosyn Corp Aktie

Aktien

Schlusskurs Other OTC Andere Börsenplätze
- ^USD	-

IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	16.07.08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	17.05.08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	31.03.08
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	26.02.08
Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	01.02.08

Manager	Titel	Alter	Seit
Stephen D. Ferrone CEO	Chief Executive Officer	73	15.10.07
Douglas A. McClain DFI	Director of Finance/CFO	49	-

Aufsichtsräte	Titel	Alter	Seit
Douglas A. McClain DFI	Director of Finance/CFO	49	-
Stephen D. Ferrone CEO	Chief Executive Officer	73	15.10.07

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	+2,41 %	93,98 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	-3,42 %	37,69 Mrd.
BIOGEN INC.	-12,43 %	32,99 Mrd.
UCB	+75,98 %	28,27 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-11,70 %	16,17 Mrd.
INCYTE CORPORATION	+1,53 %	14,33 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,82 %	11,44 Mrd.
ALTEOGEN INC.	+190,36 %	10,96 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-54,07 %	9,26 Mrd.